Radiation exposure does not appear to be associated with malignant intracranial tumors among radiologic technologists.
Radiologic technologists’ radiation exposure to the brain is not associated with malignant intracranial tumor mortality, according to a study published in the American Journal of Roentgenology. Researchers from Maryland, New York, Minnesota, and California sought to determine the association between protracted, low-to-moderate doses of radiation and malignant intracranial tumor mortality among radiologic technologists. The study included 83,655 female and 26,642 male radiologic technologists in the United States. All were certified for at least two years. The cohort was followed from the completion date of the first (1983 to 1989) or second survey (1994 to 1998) to the date of death, loss to follow-up, or Dec. 31, 2012, whichever was earliest. Occupational brain doses through 1997 were based on work history, historical data, and, for most years after the mid 1970s, individual film badge measurements. Radiation-related excess relative risks (ERRs) and 95 percent CIs were estimated from Poisson regression models adjusted for attained age and sex. The results showed the cumulative mean absorbed brain dose of the technologists was 12 mGy (range, 0 to 290 mGy). During follow-up of a median, 26.7 years, 193 technologists were noted to have died of a malignant intracranial neoplasm. Based on models incorporating a five-year lagged cumulative brain dose, cumulative brain dose was not associated with malignant intracranial tumor mortality, the researchers wrote. The researchers concluded cumulative occupational radiation exposure to the brain was not associated with malignant intracranial tumor mortality among this nationwide cohort of radiologic technologists.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Stroke MRI Study Assesses Impact of Motion Artifacts Upon AI and Radiologist Lesion Detection
August 2nd 2025Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
August 2nd 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
August 2nd 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.